Previous 10 | Next 10 |
home / stock / eprx:cc / eprx:cc news
Eupraxia Pharmaceuticals to Present at H.C. Wainwright Global Investment Conference Canada NewsWire VICTORIA, BC , Sept. 7, 2022 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology compan...
Eupraxia Pharmaceuticals Reports Second Quarter 2022 Financial Results Canada NewsWire VICTORIA, BC , Aug. 12, 2022 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with a...
Eupraxia Pharmaceuticals Recognized as Emerging Life Sciences Company of the Year by Life Sciences British Columbia Canada NewsWire VICTORIA, BC , July 7, 2022 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-sta...
Eupraxia Pharmaceuticals to Present at BIO International Convention Canada NewsWire VICTORIA, BC , June 8, 2022 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) a clinical-stage biotechnology company with an innovative ...
Eupraxia Pharmaceuticals Reports First Quarter 2022 Financial Results Canada NewsWire VICTORIA, BC , May 5, 2022 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an i...
IIROC Trade Resumption - EPRX.WT.A Canada NewsWire TORONTO , April 20, 2022 /CNW/ - Trading resumes in: Company: Eupraxia Pharmaceuticals Inc. TSX Symbol: EPRX.WT.A All Issues: No Resumption (ET): 9:30 AM IIROC can make a decision to impos...
Eupraxia Pharmaceuticals Completes C$14.7 million Overnight Marketed Offering Canada NewsWire /NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ VICTORIA BC , April 20, 2022 /CNW/ - Eupraxia Pharmaceuticals Inc. (" ...
IIROC Trading Halt - EPRX.WT.A Canada NewsWire TORONTO , April 20, 2022 /CNW/ - The following issues have been halted by IIROC: Company: Eupraxia Pharmaceuticals Inc. TSX Symbol: EPRX.WT.A All Issues: No Reason: Pending Closing Halt Time (ET):...
IIROC Trade Resumption - EPRX Canada NewsWire TORONTO , April 12, 2022 /CNW/ - Trading resumes in: Company: Eupraxia Pharmaceuticals Inc. TSX Symbol: EPRX All Issues: Yes Resumption (ET): 10:15 AM IIROC can make a decision to impose a temp...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX:EPRX), is pleased to announce today that it ha...
News, Short Squeeze, Breakout and More Instantly...
Eupraxia Pharmaceuticals Inc. Company Name:
EPRX:CC Stock Symbol:
TSXC Market:
Eupraxia Pharmaceuticals Inc. Website:
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo Canada NewsWire VICTORIA, BC , July 8, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnolo...
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024 Canada NewsWire Osteoarthritis ("OA") is the leading cause of disability in older adults. The U.S. Centers for Disease Control an...
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders Canada NewsWire VICTORIA, BC , June 6, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc. (" Eupraxia " or the " Company ") (TSX: EPRX) (NASDAQ: EPRX), a cli...